Avinger Inc. (NASDAQ: AVGR) jumped 3.6%  after announcing the submission of a 501(k) application to the FDA for new Pantheris indication in in-stent restenosis (SIR) treatment in the lower extremity arteries.  Avinger’s atherectomy products show promise in in-stent restenosis treatment.  Commenting on the submission, Avinger CEO and President Jeff Soinski […]